Who owns the ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM trademark?

The ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM trademark is owned by Medarex, Inc..

What class is the ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM trademark registered in?

The ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM?

The USPTO serial number for ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM is 78053007.

What is the registration number for ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM?

ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM is registered under USPTO registration number 2778623.

ULT

USPTO Trademark Record

ABANDONED

ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM

SN 78053007·Reg 2778623·Filed Mar 14, 2001

Owner Medarex, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM (Serial No. 78053007), Registration No. 2778623, is a abandoned US trademark filed on Mar 14, 2001 by Medarex, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM (Reg. #2778623) is an abandoned US trademark that was filed in 2001 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 14, 2001

SERIAL

78053007

REG#

2778623

REGISTERED

Oct 28, 2003

Owner

Applicant

Medarex, Inc.

Entity

Corporation

State

Address

707 State Road, Princeton, NJ, 08540

Country

Attorney

NameMarilyn F. Kelly

Law firm

Marilyn F. Kelly Bristol-Myers Squibb Company

Address

345 Park Avenue, Trademark Department, New York, NY 10154, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 14, 2001

Serial Number78053007

Registration No.2778623

Registration DateOct 28, 2003

Status DateMay 30, 2014

Published for OppositionJun 18, 2002

Mark TypeTypeset (words/letters/numbers)

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2001

YEARS AGO

25y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 23, 2003

First use in commerce: Jun 23, 2003

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

26 events

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

May 30, 2014

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 19, 2011

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 19, 2011

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Oct 31, 2009

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 30, 2009

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 19, 2009

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 19, 2009

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS SECTION 8 & 15 RECEIVED

Oct 19, 2009

TEAS SECTION 8 & 15 RECEIVED

REGISTERED-PRINCIPAL REGISTER

Oct 28, 2003

REGISTERED-PRINCIPAL REGISTER

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 23, 2003

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

ASSIGNED TO EXAMINER

Aug 21, 2003

ASSIGNED TO EXAMINER

CASE FILE IN TICRS

Aug 20, 2003

CASE FILE IN TICRS

STATEMENT OF USE PROCESSING COMPLETE

Aug 09, 2003

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Jul 03, 2003

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Jul 02, 2003

TEAS STATEMENT OF USE RECEIVED

SOU EXTENSION 1 GRANTED

May 10, 2003

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Mar 06, 2003

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Mar 06, 2003

SOU EXTENSION 1 FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

Sep 10, 2002

NOA MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 18, 2002

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

May 29, 2002

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 29, 2001

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 19, 2001

ASSIGNED TO EXAMINER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 21, 2001

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION MAILED

Jul 12, 2001

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Jul 03, 2001

ASSIGNED TO EXAMINER

ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Medarex, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Marilyn F. Kelly

Resources

Company